Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of lesinurad plus febuxostat versus febuxostat alone in gout with tophi
2011-003768-55Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in gout comparing Lesinurad + febuxostat with Febuxostat + placebo (2 arms). Primary endpoint: Serum uric acid < 5.0 mg/dL at Month 6. Started Mar 2012; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on 2011-003768-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003768-55.